Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $0.0 | $0.0 | ($8,789.2K) | ($8,109.0K) | ($5,529.0K) | $3,661.0K | $18.4M | $35.8M | $46.6M | $100.1M | $176.3M | $278.4M | $378.4M | $492.1M | $663.9M | $931.5M | $1,280.1M | $1,680.5M | $1,883.1M | $2,288.9M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, DexCom, Inc.'s last 12-month Gross Profit is $2,439.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, DexCom, Inc.'s Gross Profit growth was 12.2%. The average annual Gross Profit growth rates for DexCom, Inc. have been 21.3% over the past three years, 23.6% over the past five years.
Over the last year, DexCom, Inc.'s Gross Profit growth was 12.2%, which is higher than industry growth of 0.0%. It indicates that DexCom, Inc.'s Gross Profit growth is Good.